Sinopharm COVID‑19 Vaccine to Arrive in Singapore – Boosting Local Immunity

Sinopharm COVID‑19 Vaccine to Arrive in Singapore – Boosting Local Immunity

Singapore Eyes Sinopharm Vaccine: What You Need to Know

Why This Matters

Got your shots in line? If you’ve already taken Pfizer or Moderna, you might wonder what’s next. Singapore’s upcoming Sinopharm vaccine could become the country’s fourth Covid‑19 option, helping to lift social restrictions and kick the economy back into full gear.

How It’s Coming

The Special Access Route (SAR) is the fast‑track path that lets private health groups import vaccines that the WHO has listed for emergency use. With SAR approval, the government’s are pretty much giving the green light to bring in Sinopharm, Sinovac, Johnson & Johnson, and Oxford‑AstraZeneca.

Who’s Working on It

  • IHH Healthcare Singapore – They told The Straits Times the Health Sciences Authority has already signed off on the import. “This will give people in Singapore access to another alternative vaccine option,” Dr Noel Yeo said. They’re still ironing out the details, but a formal announcement is on the horizon.
  • Raffles Medical Group – Their Facebook page is asking folks to register interest in the Chinese vaccine, the one that uses an inactivated virus to launch a defence against Covid‑19. The Straits Times has reached out for more commentary.

What Else Is in the Pipeline

  • Novavax, the American biotech firm, has an advance purchase agreement. If all goes well, their protein‑based jab could ship before year’s end and join the national roll‑out.
  • It’s worth noting that SAR vaccines are non‑subsidised – no government cash to cover them. Nor are they protected by the Vaccine Injury Financial Assistance Programme.

Key Facts About Sinopharm

  • Two‑dose schedule, 3‑4 weeks apart.
  • Target age: 18 and up.
  • WHO reports 79% protection against symptomatic disease and workplace hospitalisation after the second dose.
  • Singapore has already vaccinated 4.3 million people. Three‑quarters have finished the full regimen.
  • Now, a total of 89,047 Sinovac doses have gone out.

So, will Sinopharm become part of Singapore’s national vaccine arsenal? Only time will tell – but the groundwork is laid and the countdown has begun. Stay tuned for the next announcement!